FSFabian Spahiu

Fabian Spahiu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fabian Spahiu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Peak Cardiac Mechanical and Haemodynamic Responses During Incremental Exercise Are Temporally Associated With Ventilatory Thresholds: Novel Insight Into the Coordination of Integrative Physiological Responses to Exercise

    by Fabian Spahiu, Moritz Lampkemeyer, Michelle Ottlik, Max Hagemann, Lars C. Helbig, Eric J. Stöhr

    Background: Maximal aerobic capacity (VO 2 peak) is traditionally attributed to limitations in oxygen transport and utilization. However, it remains unclear whether peak cardiac mechanical and haemodynamic responses occur in temporal association to ventilatory thresholds during incremental exercise, and whether these relationships vary with cardiorespiratory fitness. Methods: Eighteen healthy, recreationally active adults (26 ± 3.18 years VO 2 peak 41.87 ± 4.76 mL·kg·min −1 ) completed two incremental supine cycling tests to exhaustion, with breath‐by‐breath gas exchange analysis, exercise echocardiography, and continuous blood pressure monitoring. Plateau timing (PT) was defined as the relative heart rate (%HRmax) at which each cardiovascular variable reached its peak or plateau response. Associations between cardiovascular PTs, VO 2 peak, and the first (VT1) and second ventilatory thresholds (VT2) were examined using correlation analysis. Exploratory k‐means clustering was used to descriptively visualize plateau‐timing distributions. Results: VT1 significantly correlated with PT–ejection fraction (EF) and PT–vascular conductance, whereas VT2 correlated with deformation‐based parameters including PT–apical circumferential strain, PT–apical rotation, and iCarT ( p < 0.05). VO 2 peak was positively associated with PT–twist and PT–apical rotation ( p < 0.05), and negatively associated with PT–EF ( p < 0.05). Exploratory clustering yielded two descriptive clusters which differed in VO 2 peak ( p < 0.05) and were characterized by differences in volumetric and rotational plateau‐timing distributions. Conclusions: During exercise, different cardiac parameters are temporally associated with ventilatory thresholds 1 and 2. Cardiorespiratory fitness may influence interindividual differences in the temporal organization of response patterns during incremental exercise.

  • Open Access

    Identification of the individual cardiac contraction threshold during high‐frame‐rate stress echocardiography

    by Fabian Spahiu, Max Hagemann, Michelle Ottlik, Moritz Lampkemeyer, Eric J. Stöhr

    The clinical assessment of cardiovascular function during exercise using stress echocardiography is essential for accurate cardiac diagnosis. However, normal limitations of cardiac deformation responses to increasing physical exertion remain poorly understood. We introduce the individual cardiac contraction threshold (iCarT) as a novel marker of mechanical cardiac limitation and examine its relationship to standard cardiovascular measures.High‐frame‐rate (121–276 frames/s) exercise echocardiography was performed during stepwise cardiopulmonary exercise testing on a recumbent cycle ergometer in 19 healthy, recreationally active adults. Visit 1 was used to individualie exercise protocols, applied in Visit 2. Left ventricular (LV) peak twist, longitudinal strain (LS), and apical circumferential strain (ACS) were assessed at each exercise stage. Polynomial curve fitting was used to identify plateaus in deformation parameters. iCarT was defined as the relative heart rate, expressed as a percentage of maximum heart rate (% HR m a x ), at which the final deformation parameter reached its maximum. Associations between iCarT and the timing of plateau onset in volumetric and vascular measures were analysed using Spearman and Pearson correlations.At the group level ( n = 19), LS plateaued first (76% HR m a x ), followed by ACS (82% HR m a x ) and LV twist (83% HR m a x ). iCarT occurred at 89 ± 13% HR m a x . At the individual level, among participants with complete deformation data ( n = 12), 50% did not show a clear deformation plateau. In participants displaying iCarT ( n = 6), LV twist was the final parameter to level off in 83%. iCarT showed no association with stroke volume, cardiac output, end‐systolic volume, or ejection fraction. iCarT identifies individual limits of cardiac deformation during exercise, characterized by marked interindividual variability. Its independence from conventional cardiovascular measures highlights the added value of deformation‐based thresholds, with LV twist emerging as the most robust parameter during increasing effort.


  • Open Access

    Effects of 12 Weeks of Calanus Oil Supplementation on Cardiac Diastolic Function in Obese and Prediabetic Women—A Pilot Study

    by Felix Kerlikowsky, Fabian Spahiu, Eric J. Stöhr, Sina Junge, Wiebke Jonas, Edda van de Flierdt, Jan Philipp Schuchardt, Andreas Hahn

    Background/Objectives: In early-stage diabetes, diastolic dysfunction is an initial indicator of heart failure and is linked to altered glucose metabolism, including in prediabetes. Based on initial evidence that Calanus oil, derived from Calanus finmarchicus, which is rich in omega-3 polyunsaturated fatty acids and other bioactive compounds, benefits metabolic and cardiorespiratory health, this proof-of-principle study aimed to assess whether Calanus oil improves diastolic function in prediabetic women. Methods: Twenty middle-aged, obese women with prediabetes and no history of cardiac complications were enrolled and received 4 g/day of Calanus oil, providing 276 mg EPA + 256 mg DHA, for 12 weeks. Systolic and diastolic cardiac function, including the E/A ratio (E/A), was assessed by echocardiography. In addition, central blood pressure (BP) and pulse wave velocity (PWV) were analyzed by oscillometry. Metabolic health was evaluated using composite markers, including the metabolic syndrome severity score (Met-S score) and the triacylglycerol glucose–waist-to-height ratio (TyG-WHtR). Results: E/A was significantly improved (p = 0.023) following 12 weeks of Calanus oil supplementation. Furthermore, a significant improvement in metabolic health, indicated by a reduced Met-S score and a lower TyG-WHtR, was noticed (p < 0.001, respectively), reflecting decreased metabolic syndrome severity and enhanced insulin sensitivity. In addition, a significant reduction in diastolic BP, resting heart rate (p = 0.047), but not PWV or systolic BP (all p > 0.05) was observed. The improvement in E/A was associated with improved insulin sensitivity, as reflected by a decrease in the TyG-WHtR (p = 0.014). Conclusions: These exploratory findings suggest that Calanus oil supplementation in pre-diabetic women might improve central diastolic haemodynamics, accompanied by an overall improvement in metabolic health. However, the absence of a placebo control group limits definitive conclusions.


  • Open Access

    Effects of 12 Weeks of Calanus Oil Supplementation on Cardiac Diastolic Function in Obese and Prediabetic Women – A Pilot Study

    by Felix Kerlikowsky, Fabian Spahiu, Eric J. Stöhr, Sina Junge, Wiebke Jonas, Edda van de Flierdt, Jan Philipp Schuchardt, Andreas Hahn

    Background/Objectives: In early-stage diabetes, diastolic dysfunction is an initial indicator of heart failure and is linked to altered glucose metabolism, including in prediabetes. Based on initial evidence that Calanus oil, derived from Calanus finmarchicus which is rich in omega-3 polyunsaturated fatty acids and other bioactive compounds, benefits metabolic and cardiorespiratory health, this proof-of-principle study aimed to assess whether CALANUS OIL improves diastolic function in prediabetic women. Methods: Twenty middle-aged, obese women with prediabetes and no history of cardiac complications were enrolled and received 4 g/day of Calanus oil, providing 276 mg EPA+256 mg DHA, for 12 weeks. Systolic and diastolic cardiac function, including the E/A ratio (E/A), was assessed by echocardiography. In addition, central blood pressure (BP) and pulse wave velocity (PWV) were analysed by oscillometry. Metabolic health was evaluated using composite markers, including the metabolic syndrome severity score (Met-S score) and the triacylglycerol-glucose waist-to-height ratio (TyG-WHtR). Results: E/A was significantly improved (p=0.023) following 12 weeks of Calanus oil supplementation. Furthermore, a significant improvement in metabolic health indicated by a reduced Met-S score and a lower TyG-WHtR was noticed (p < 0.001, respectively), reflecting decreased metabolic syndrome severity and enhanced insulin sensitivity. In addition, a significant reduction in diastolic BP, resting heart rate (p=0.047) but not PWV or systolic BP (all p>0.05) were observed. The improvement in E/A was associated with improved insulin sensitivity, as reflected by a decrease in the TyG-WHtR (p=0.014). Conclusions: In prediabetic women, Calanus oil supplementation improved central diastolic haemodynamics, accompanied by an overall improvement of metabolic health.

  • Open Access

    Elevated frame rates during exercise echocardiography improve speckle-tracking success rate and augment deformation values

    by Fabian Spahiu, Michelle Ottlik, Lars C. Helbig, Eric J. Stöhr

    This study demonstrates the benefits of high frame per second (HFPS) rate settings in speckle-tracking echocardiography, achieving superior-tracking success and higher deformation values, including longitudinal strain and untwisting velocity, compared with lower frame rates. These advantages, particularly evident at elevated heart rates, highlight the importance of high temporal resolution for accurate cardiac imaging under stress conditions. The findings support prioritizing HFPS in clinical and research settings to improve tracking reliability and data accuracy.